<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00790179</url>
  </required_header>
  <id_info>
    <org_study_id>1989md</org_study_id>
    <nct_id>NCT00790179</nct_id>
  </id_info>
  <brief_title>Continuous Lumbar Plexus Block for Postoperative Pain Control After Total Hip Arthroplasty</brief_title>
  <official_title>Continuous Lumbar Plexus Block for Postoperative Pain Control After Total Hip Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwell Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwell Health</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Continuous lumbar plexus and femoral blocks have been demonstrated to provide effective
      postoperative analgesia of the lower extremity following total joint arthroplasty. The
      purpose of this study was to compare these two techniques when used with intravenous
      patient-controlled analgesia and the use of patient-controlled analgesia alone for
      postoperative pain management following unilateral total hip arthroplasty.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      above may be applied
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2003</start_date>
  <completion_date type="Actual">March 2007</completion_date>
  <primary_completion_date type="Actual">January 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VAS pain scores</measure>
    <time_frame>at 24 and 48 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>hydromorphone consumption,patient satisfaction,distance ambulated, opioid-related side effects</measure>
    <time_frame>at 24 and 48 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">225</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>PCA;active comparator</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with intravenous PCA hydromorphone alone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CFB</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with a continuous femoral block (CFB) + PCA hydromorphone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CLPB</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with a continuous lumbar plexus block + PCA hydromorphone</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>continuous infusion of ropivacaine via CLPB vs. CFB vs IV PCA</intervention_name>
    <description>0.5% Ropivacaine bolus of 30 ml. followed by ropivacaine 0.2%at 10 ml/hr via CLPB vs. CFB.
Hydromorphone 0.3 mg demand only every 10 minutes via IV PCA.</description>
    <arm_group_label>PCA;active comparator</arm_group_label>
    <arm_group_label>CFB</arm_group_label>
    <arm_group_label>CLPB</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-80 years old

          -  primary diagnosis of osteoarthritis

        Exclusion Criteria:

          -  allergy to local anesthetics

          -  peripheral neuropathy

          -  opioid dependency

          -  dementia

          -  coagulopathy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph Marino, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Huntington Hospital</affiliation>
  </overall_official>
  <verification_date>November 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 12, 2008</study_first_submitted>
  <study_first_submitted_qc>November 12, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 13, 2008</study_first_posted>
  <last_update_submitted>November 12, 2008</last_update_submitted>
  <last_update_submitted_qc>November 12, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 13, 2008</last_update_posted>
  <responsible_party>
    <name_title>Joseph Marino M.D.</name_title>
    <organization>Huntington Hospital, North Shore-LIJ Health System</organization>
  </responsible_party>
  <keyword>Continuous lumbar plexus,Femoral,hydromorphone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Hydromorphone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

